青光眼与高眼压激光试验中视野进展的六年速率
该研究为随机临床试验的事后分析,比较选择性激光小梁成形术(SLT)与滴眼液作为高眼压(OHT)和开角型青光眼(OAG)一线治疗6年视野(VF)进展速率。共分析710眼,SLT优先组平均偏差(MD)进展速率为-0.26 dB/年,慢于滴眼液优先组的-0.37 dB/年(P=0.007)。作者认为一线SLT在保留视野方面比滴眼液更有效,应优先作为新诊断OHT和OAG的一线治疗。
要点
- SLT优先组MD进展速率-0.26 dB/年,滴眼液优先组-0.37 dB/年,差异P=0.007。
- 按严重程度分层,仅轻度OAG亚组差异显著(P=0.035)。
- 使用平均模式偏差(MPD)的次要分析同样显示SLT优先组进展更慢(P<0.001)。
核心结论
- 一线SLT在保留视野方面比滴眼液更有效。
- 作者认为,对于新诊断的OHT和OAG眼,应优先选择SLT作为一线治疗。
研究设计与样本
- 研究设计为随机临床试验的事后分析,数据来自LiGHT试验。
- 纳入新诊断的OHT/OAG患者,每例选择基线MD较好且至少6个月内至少有3次可靠视野检查(假阳性错误<15%)的合格眼,共分析710眼(482眼OAG,354眼在SLT优先组)。
主要发现
- 两臂基线MD相似(P=0.7)。
- 随访期间平均眼压:滴眼液优先组16.1 [14.2-18.2] mmHg,SLT优先组16.8 [14.6-18.6] mmHg(中位数[四分位距],P=0.057)。
- 平均[95%可信区间]MD进展速率:滴眼液优先组-0.37 [-0.43至-0.31] dB/年,SLT优先组-0.26 [-0.31至-0.21] dB/年(P=0.007)。
- 按严重程度分层,该差异仅在轻度OAG亚组显著(P=0.035,该亚组最大)。
- 使用MPD的次要分析显示SLT优先组进展速率也显著更慢(P<0.001)。
关键数值与推荐
- 主要结局为SLT优先组与滴眼液优先组之间VF MD进展速率的平均差异。
- MD进展速率使用已发表的层次线性混合效应模型(LMM)估计,该模型旨在通过最小化视野学习效应和重测噪声的影响来提高精确度。
临床怎么用
- 作者认为,对于新诊断的OHT和OAG眼,应优先选择SLT作为一线治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the 6-year rate of visual field (VF) progression in the 2 arms of the Laser in Ocular Hypertension and Glaucoma Trial (LiGHT), comparing selective laser trabeculoplasty (SLT) and drops as first treatment in ocular hypertension (OHT) and open-angle glaucoma (OAG). DESIGN: Post hoc analysis of data from randomized clinical trial. PARTICIPANTS: Patients with newly diagnosed OHT/OAG recruited in the LiGHT trial. METHODS: In each patient, we selected the better (baseline mean deviation [MD]) eligible eye with at least 3 reliable VFs (false-positive errors < 15%) over at least 6 months. We estimated the rate of MD progression using a published hierarchical linear mixed effect model (LMM), designed to increase precision by minimizing the effect of perimetric learning and test-retest noise. Secondary analyses were performed to assess the differences in rate across baseline severity groups (OHT, mild OAG, and moderate/severe OAG); the effect of glaucoma surgery and switch to SLT in the drops-first arm, by truncating the VF series; and the effect of cataract and cataract surgery, by using the mean pattern deviation (MPD) instead of the MD. MAIN OUTCOME MEASURE: Mean difference in the rate of VF MD progression between patients in the SLT-first arm and drops-first arm. RESULTS: Data from 710 eyes (482 with OAG and 354 in the SLT-first arm) were analyzed. The 2 arms had similar baseline MD (P = 0.7). The average intraocular pressure (IOP) during follow-up was 16.1 [14.2-18.2] for the drops-first arm and 16.8 [14.6-18.6] in the SLT-first arm (median [interquartile range], P = 0.057). The mean [95% credible interval] MD rate was -0.37 [-0.43 to -0.31] decibels (dB)/year in the drops-first arm and -0.26 [-0.31 to -0.21] dB/year in the SLT-first arm (P = 0.007). When stratified by severity, this difference was significant only in mild OAG (P = 0.035, the largest sub-group). The secondary analyses largely confirmed the main results. The difference in MPD rate was also significantly slower in the SLT-first arm (P < 0.001). CONCLUSIONS: First-line SLT was more effective than drops at preserving VF. Selective laser trabeculoplasty should be preferred as the first line of treatment in newly diagnosed OHT and OAG eyes. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- Montesano G, Crabb DP, Garway-Heath DF, et al. Six-Year Rate of Visual Field Progression in the Laser in Glaucoma and Ocular Hypertension Trial. Ophthalmology. 2025. PMID: 41043781. doi:10.1016/j.ophtha.2025.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。